GlobeNewswire Inc.··DelveinsightGlioblastoma Market to Surge 13.2% Annually as Next-Gen Therapies Advance
Glioblastoma market valued at $900M to grow 13.2% annually through 2036, driven by next-generation immunotherapies and precision medicine approaching late-stage development.
MRKNVSRHHBYTLRYBAYRY+4clinical trialspersonalized medicine